Polymers,
Journal Year:
2024,
Volume and Issue:
16(24), P. 3485 - 3485
Published: Dec. 13, 2024
The
present
study
aimed
to
explore
an
ideal
delivery
system
for
triptolide
(TPL)
by
utilizing
the
thin-film
hydration
method
prepare
drug-loaded,
folate-modified
mixed
pluronic
micelles
(FA–F-127/F-68–TPL).
Scanning
electron
microscopy
and
atomic
force
showed
that
drug-loaded
had
a
spherical
shape
with
small
particle
size,
average
of
30.7
nm.
Cell
viability
experiments
FA–F-127/F-68–TPL
significantly
reduced
HepG2
cell
viability,
exhibiting
strong
cytotoxicity.
Its
cytotoxicity
was
markedly
enhanced
compared
bare
TPL.
Nile
red
(Nr)
used
as
model
drug
FA–F-127/F-68–Nr
further
validate
its
tumor-targeting
cellular
uptake
capability.
After
coincubation
cells,
multifunctional
microplate
reader
intracellular
fluorescence
intensity
increased,
indicating
could
more
effectively
enter
cells.
A
nude
mouse
subcutaneous
hepatocellular
carcinoma
constructed.
Following
tail
vein
injection
FA–F-127/F-68–Nr,
imaging
FA–F127/F-68–Nr
target
tumor
tissue,
even
if
entering
small-sized
challenging,
it
be
excreted
through
urine.
Nude
mice
were
treated
injections
(45
µg/kg)
every
other
day
21
days.
results
growth
transplanted
tumors
slowed,
no
significant
difference
In
summary,
exhibits
advantages
low
cost,
excellent
biological
properties,
active/passive
targeting
capabilities,
notable
against
liver
cancer
inhibition
growth.
Significantly,
FA–F-127/F-68–TPL,
despite
challenges
in
insignificant
EPR
effect,
can
efficiently
via
kidneys,
thereby
preventing
release
during
prolonged
circulation
potential
damage
normal
tissues.
Therefore,
represents
promising
antitumor
system.
Cancer Nanotechnology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 17, 2025
Emphasizing
the
significance
of
cancer-associated
fibroblasts
(CAFs),
non-malignant
yet
pivotal
players
within
tumor
microenvironment
(TME),
this
review
illuminates
role
inflammatory
subtype
(iCAF)
as
catalysts
in
cancer
proliferation,
metastasis,
and
therapeutic
resistance.
Given
their
paramount
importance,
targeting
CAFs
emerges
a
robust
strategy
evolving
landscape
immunotherapy.
Nanomaterials,
distinguished
by
unique
features
malleability,
hold
considerable
promise
biomedicine,
especially
precision-oriented
domain
therapy.
Their
aptitude
for
modulating
immune
responses,
amplifying
drug
efficacy
through
precise
delivery,
discerningly
focusing
on
cells
TME
situates
nanomaterials
formidable
tools
to
transcend
boundaries
set
conventional
treatments.
This
scrutinizes
convoluted
interplay
among
CAFs,
cells,
TME.
It
further
showcases
widely
utilized
management.
We
underscore
potential
nanoscale
delivery
systems
directed
at
underscoring
transformative
power
revolutionizing
therapies,
enhancing
precision,
culminating
improved
patient
outcomes.
International Journal of Nanomedicine,
Journal Year:
2025,
Volume and Issue:
Volume 20, P. 2103 - 2118
Published: Feb. 1, 2025
Lung
cancer,
a
deadly
malignancy,
often
employs
Docetaxel
(DTX)
as
chemotherapy
option.
However,
DTX
non-selective
distribution
limits
its
therapeutic
effectiveness
due
to
adverse
side
effects.
This
study
aims
develop
novel
folate-targeted
albumin
polyester
nanocarriers
(FA-DTX-APs)
encapsulating
for
precise
delivery,
enhancing
lung
cancer
treatment
efficacy.
FA-DTX-APs
were
meticulously
crafted
utilizing
the
thin-film
dispersion
technique
and
subsequently
evaluated
their
physicochemical
characteristics,
encapsulation
efficiency,
drug
release
profiles.
To
assess
biological
properties,
anti-tumor
efficacy,
biosafety
in
context
of
comprehensive
series
hemolysis
assays,
cellular
studies,
animal
experiments
conducted.
exhibit
nanovesicle
properties
with
size
(223.65
±
6.83)
nm,
potential
(26.76
3.15)
mV,
encapsulate
high
efficiency
(96.19
3.27%)
loading
capacity
(9.75
0.38%).
enable
tumor-targeted
delivery
slow
over
long
period
time,
faster
acidic
environments.
By
efficiently
targeting
entering
cells,
effectively
hinder
growth
(P
<
0.05),
demonstrating
superior
effects
biocompatibility
enhanced
safety
0.05).
introduces
FA-DTX-APs,
an
innovative
nanocarrier
characterized
by
exceptional
safety.
It
successfully
targets
cells
deliver
sustained,
slow-release
manner,
ensuring
prolonged
tumor-killing
As
such,
hold
immense
promise
nanoagent
therapy.
Cells,
Journal Year:
2025,
Volume and Issue:
14(4), P. 287 - 287
Published: Feb. 15, 2025
Patients
with
treatment-refractory/relapsing
germ
cell
tumors
(GCTs)
have
a
dismal
prognosis
due
to
lack
of
any
effective
therapy.
Moreover,
the
efficacy
newly
approved
targeted
therapies
remains
unexplored
for
cisplatin-resistant
GCTs.
Previously,
it
was
demonstrated
that
folate
receptor
α
(FRα)
is
overexpressed
in
many
tumor
types
and
efficiently
by
antibody-drug
conjugate
(ADC)
mirvetuximab
soravtansine
(MIRV)
cancers.
We
hypothesized
FRα
represents
an
attractive
target
treating
treatment-refractory
determined
expression
FOLR1
gene
broad
range
GCT
lines
xenografts.
tested
antitumor
MIRV
on
cells
vitro
explored
ability
treatment
induce
bystander
effect
direct
coculture
FRα-high
FRα-low
cells.
found
has
significantly
higher
testicular
GCTs
(TGCTs)
than
normal
tissue.
highly
expressed
TCam2,
JEG3,
JAR,
NOY1
their
respective
variants.
induced
apoptosis
potent
antiproliferative
adherent
3D
spheroid
cultures
vitro.
A
significant
decrease
2102EP_R_NL
observed
presence
NOY1_R_SK
12.5
nM
MIRV,
showing
coculture.
Immunohistochemical
analysis
confirmed
Folr1
protein
patients
TGCTs
postchemotherapy
chemo-naïve
patients,
as
well
unfavorable
prognosis.
In
this
study,
we
present
data
suggesting
(T)GCT
vivo,
anti-FRα-targeting
should
be
investigated
modality
subset
TGCTs.
effects,
thus
its
potential
further
preclinical
exploration
drug
repurposing
salvage
regime
refractory
disease.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(6), P. 1297 - 1297
Published: March 13, 2025
Chitosan
(CS)
occurs
naturally
as
an
alkaline
polysaccharide
and
has
been
demonstrated
to
have
several
activities
of
a
biological
nature.
Additionally,
CS
chains
functional
hydroxyl
amino
groups
that
are
active,
their
applications
can
be
expanded
by
chemically
or
molecularly
altering
the
molecules
incorporate
new
groups.
Due
its
outstanding
qualities,
including
biodegradability,
biocompatibility,
non-toxicity,
accessibility,
it
received
significant
interest
in
all
areas
biomedicine
nanomaterials
being
extremely
promising
drug
nanocarrier.
The
last
decades
produced
lot
CS-based
nanoparticles
(CSNPs),
with
increasing
number
research
papers
from
around
1500
2015
almost
5000
2024.
degree
crosslinking,
particulate
system’s
shape,
size,
density,
addition
drug’s
physical
chemical
properties,
role
how
is
transported
released
CSNPs.
When
creating
potential
delivery
systems
based
on
CSNPs,
these
factors
must
considered.
In
earlier,
CSNPs
were
employed
enhance
pharmacotherapeutics,
pharmacokinetics,
solubility
properties
drugs.
By
investigating
positively
charged
characteristics
changeable
groups,
evolved
into
versatile
system.
release
will
definitely
influenced
various
changes
charges,
polymer
backbone.
This
review
mainly
discusses
most
important
results
published
decade.
Despite
advantages
challenges
related
translation
clinical
stages
remain
further
vitro
vivo
studies
mandatory.
Exploration of Targeted Anti-tumor Therapy,
Journal Year:
2025,
Volume and Issue:
6
Published: March 18, 2025
Pancreatic
cancer
is
a
challenging
disease
with
limited
treatment
options
and
high
mortality
rate.
Just
few
therapy
advances
have
been
made
in
recent
years.
Tumor
microenvironment,
immunosuppressive
features
mutational
status
represent
important
obstacles
the
improvement
of
survival
outcomes.
Up
to
now,
first-line
did
achieve
median
overall
less
than
12
months
this
discouraging
data
lead
clinicians
all
over
world
focus
their
efforts
on
various
fields
investigation:
1)
sequential
cycling
different
systemic
order
overcome
mechanisms
resistance;
2)
discovery
new
predictive
bio-markers,
target
specific
patient
population;
3)
combination
treatment,
modulate
tumor
microenvironment
pancreatic
cancer;
4)
modalities
delivery
drugs
pass
physical
barrier
desmoplasia
stroma.
This
review
shows
future
directions
strategies
advanced
through
deep
analysis
these
macro
areas
research.
Inorganics,
Journal Year:
2025,
Volume and Issue:
13(4), P. 98 - 98
Published: March 21, 2025
With
the
unprecedented
progress
of
biomedical
nanotechnology
in
past
few
decades,
traditional
drug
delivery
systems
(DDSs)
have
been
incorporated
into
intelligent
DDSs
with
stimulus
responsive
characteristics.
Graphene
oxide
(GO)
and
Chitosan
(CS)
excellent
physical,
chemical,
mechanical,
optical
properties,
their
synergistic
effects
attracted
widespread
attention
field.
In
this
review,
we
focus
on
physicochemical
characteristics
GO,
CS,
GO/CS
composites,
as
well
research
DDS
types
based
GO/CS.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(4), P. 564 - 564
Published: April 13, 2025
Despite
improvements
in
therapeutic
approaches
like
immunotherapy
and
gene
therapy,
cancer
still
remains
a
serious
threat
to
world
health
due
its
high
incidence
mortality
rates.
Limitations
of
conventional
therapy
include
suboptimal
targeting,
multidrug
resistance,
systemic
toxicity.
A
major
challenge
current
oncology
therapies
is
the
development
new
delivery
methods
for
antineoplastic
drugs
that
act
directly
on
target.
One
approach
involves
complexation
antitumor
with
cyclodextrins
(CDs)
chitosan
(CS)
as
an
attempt
counteract
their
primary
limitations:
low
water
solubility
bioavailability,
diminished
vitro
vivo
stability,
dose-dependent
All
those
drawbacks
may
potentially
exclude
some
candidates
from
clinical
trials,
thus
integration
into
smart
systems
or
drug-targeting
technologies
must
be
implemented.
We
intended
overview
drug
based
regard
diagnosis
management.
This
narrative
review
encompasses
full-length
articles
published
English
between
2019
2025
(including
online
ahead
print
versions)
PubMed-indexed
journals,
focusing
recent
research
encapsulation
diverse
within
nanosystems
exhibit
responsiveness
various
stimuli
such
pH,
redox
potential,
folate
receptor
levels,
thereby
enhancing
release
bioactive
compounds
at
tumor
sites.
The
majority
cited
references
focus
most
notable
research,
studies
novel
applications,
scientific
advancements
field
nanostructures
functional
materials
employed
oncological
over
last
six
years.
Certainly,
there
are
additional
potential
can
facilitate
drug’s
upon
activation,
reactive
oxygen
species
(ROS),
enzymes,
ATP
level,
hypoxia;
however,
our
exclusively
addresses
aforementioned
presented
comprehensive
manner.